A multicenter phase II study of vorinostat in patients (pts) with relapsed or refractory indolent B-cell non-Hodgkin lymphoma (B-NHL) or mantle cell lymphoma (MCL).

被引：0
|
作者：
Ando, Kiyoshi
Ogura, Michinori
Suzuki, Tatsuya
Ishizawa, Kenichi
Oh, Sung Yong
Kim, Won Seog
Tanaka, Yoshinobu
Shimamoto, Takashi
Tobinai, Kensei
机构：
[1] Tokai Univ, Dept Hematol & Oncol, Hiratsuka, Kanagawa 25912, Japan
[2] Nagoya Daini Red Cross Hosp, Nagoya, Aichi, Japan
[3] Tohoku Univ Hosp, Sendai, Miyagi, Japan
[4] Dong A Univ, Coll Med, Dept Internal Med, Pusan, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
[6] MSD KK, Tokyo, Japan
[7] Natl Canc Ctr, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8029
引用
收藏
页数：1
相关论文
共 50 条
  • [41] TANDEM AUTOLOGOUS ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED/REFRACTORY MATURE B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
    Gardenswartz, A.
    Mehta, B.
    El-Mallawany, N.
    van de Ven, C.
    Hochberg, J.
    Flower, A.
    Morris, E.
    Harrison, L.
    Basso, J.
    Gerard, P.
    Ayello, J.
    Baxter-Lowe, L. A.
    Cairo, M. S.
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [42] Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma
    Spurgeon, Stephen E.
    Sharma, Kamal
    Claxton, David F.
    Ehmann, Christopher
    Pu, Jeffrey
    Shimko, Sara
    Stewart, August
    Subbiah, Nan
    Palmbach, Gundula
    LeBlanc, Francis
    Latour, Emile
    Chen, YiYi
    Mori, Motomi
    Hasanali, Zainul
    Epner, Elliot M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (06) : 845 - 854
  • [43] A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma
    Chen, Robert
    Frankel, Paul
    Popplewell, Leslie
    Siddiqi, Tanya
    Ruel, Nora
    Rotter, Arnold
    Thomas, Sandra H.
    Mott, Michelle
    Nathwani, Nitya
    Htut, Myo
    Nademanee, Auayporn
    Forman, Stephen J.
    Kirschbaum, Mark
    HAEMATOLOGICA, 2015, 100 (03) : 357 - 362
  • [44] A Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
    Christian, Beth
    Kuruvilla, John
    Smith, Sonali
    Porcu, Pierluigi
    Ruppert, Amy S.
    Byrd, John C.
    Grever, Michael R.
    Blum, Kristie A.
    BLOOD, 2014, 124 (21)
  • [45] A phase II study of Xcellerated T cells™ in patients with relapsed or refractory indolent non-Hodgkin's lymphoma (NHL)
    Gribben, JG
    Bartlett, NL
    Stephenson, JJ
    Milder, MS
    Boccia, RV
    Redfern, C
    Mizuno, VM
    Berenson, RJ
    Frohlich, MW
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 76 - 76
  • [46] Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphoma
    Ansell, Stephen M.
    Witzig, Thomas E.
    Inwards, David J.
    Porrata, Luis F.
    Ythier, Arnaud
    Ferrande, Lee
    Nestorov, Ivan
    Devries, Todd
    Dillon, Stacey R.
    Hausman, Diana
    Novak, Anne J.
    CLINICAL CANCER RESEARCH, 2008, 14 (04) : 1105 - 1110
  • [47] A phase II study of Xcellerated T Cells in patients with relapsed or refractory indolent non-Hodgkin's lymphoma (NHL)
    Gribben, JG
    Stephenson, JJ
    Bartlett, NL
    Milder, MS
    Boccia, RV
    Redfern, C
    Mizuno, VM
    Hillson, J
    Berenson, RJ
    Frohlich, MW
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 168S - 168S
  • [48] A phase II study of Xcellerated T cells™ in patients with relapsed or refractory indolent non-Hodgkin's lymphoma (NHL).
    Bartlett, NL
    Gribben, JC
    Boccia, RV
    Milder, MS
    Aboulafia, DM
    Castro, J
    Flinn, I
    Hayes-Lattin, B
    Kaplan, L
    Lin, T
    Lucas, JB
    Maloney, DG
    McLaughlin, P
    McSweeney, PA
    Mohrbacher, A
    Redfern, C
    Steis, R
    Stephenson, JJ
    Strair, R
    Berenson, RJ
    Frohlich, MW
    BLOOD, 2004, 104 (11) : 244B - 244B
  • [49] A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B-cell Non-Hodgkin Lymphoma
    Torka, Pallawi
    Patel, Priyank
    Tan, Wei
    Wilding, Gregory
    Bhat, Seema A.
    Czuczman, Myron S.
    Lee, Kelvin P.
    Deeb, George
    Neppalli, Vishala
    Mavis, Cory
    Wallace, Paul
    Hernandez-Ilizaliturri, Francisco J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (01): : E51 - E60
  • [50] The Profiling of Circulating Tumor DNA in Pediatric Mature B-Cell Non-Hodgkin Lymphoma (B-NHL): A Multicenter and Prospective Clinical Study
    Wang, Juan
    Guo, Haixia
    Yun, Cai
    Chen, Huiqin
    Yang, Liangchun
    Dou, Huihong
    Tian, Xin
    Xiong, Hao
    You, M. James
    Hong, Xiaoyu
    Liang, Chuqiao
    Zhen, Zijun
    Zhu, Jia
    Lu, Suying
    Sun, Feifei
    Huang, Junting
    Zhang, Yizhuo
    BLOOD, 2021, 138
12345